Systemic Targeted Adaptive RadioTherapy of NeuroEndocrine Tumors.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
There are several ways of personalizing PRRT (peptide receptor radionuclide treatment) in NEN (neuroendocrine neoplasia). Nevertheless, the current treatment regimen is not personalized. This trial aims to compare personalized PRRT to non-personalized PRRT in terms of safety, efficacy and resource demands in order to optimize treatment outcomes in an evidence-based manner in future.
Epistemonikos ID: cbc4b9e9126eb05be1130e55161338287313ad97
First added on: May 13, 2024